Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Redcliffe Capital is a family office and venture capital firm founded in 2008 by Dheeraj Jain and Alpesh Doshi. The firm operates from its offices in London and Delhi, focusing on early-stage investments across various sectors globally. Redcliffe Capital emphasizes innovation and sustainable value creation, particularly in technology and healthcare.
Since its inception, Redcliffe Capital has engaged in a multi-strategy investment approach, participating in seed and Series A funding rounds, as well as structured finance and leveraged buyouts. The firm is known for its active participation in 2-6 deals per year, showcasing a consistent commitment to supporting high-growth potential companies.
Redcliffe Capital's notable milestones include leading seed rounds for innovative startups like Xanadu Heights, a San Francisco-based VR company. The firm continues to expand its influence in the venture capital space, particularly in sectors such as artificial intelligence, healthcare, and fintech.
Redcliffe Capital specializes in venture capital investments and unique opportunities, with a strong emphasis on Artificial Intelligence, healthcare, and fintech. The firm primarily targets early-stage startups, focusing on seed and Series A funding rounds. In addition to traditional venture capital, Redcliffe Capital engages in special situations, structured finance, and leveraged buyouts across various industries.
The firm seeks to invest in high-growth potential companies that demonstrate innovation and sustainability. Redcliffe Capital's investment strategy is characterized by a multi-faceted approach, allowing for flexibility in deal structures and investment types. The firm values founders who are committed to their vision and possess a strong understanding of their market.
Geographically, Redcliffe Capital operates globally, with a particular focus on North America, Europe, and Asia. This broad reach enables the firm to identify and capitalize on diverse investment opportunities across different markets.
While specific portfolio companies have not been extensively disclosed, Redcliffe Capital has led seed rounds for notable startups, including:
The firm is actively involved in sectors such as healthcare and machine learning/AI, indicating a strong focus on technology-driven companies. Redcliffe Capital's investment strategy includes a mix of early-stage funding and special situations, allowing for a diverse portfolio that adapts to market trends.
Dheeraj Jain - Co-Founder. Dheeraj has extensive experience in venture capital and investment banking. He has been instrumental in leading Redcliffe Capital's investment strategy and has a strong background in technology and healthcare investments.
Alpesh Doshi - Co-Founder. Alpesh brings a wealth of knowledge in structured finance and special situations. His expertise in navigating complex investment scenarios has contributed to Redcliffe Capital's unique multi-strategy approach.
To pitch Redcliffe Capital, founders should send an email to info@redcliffecapital.com. It is essential to include a comprehensive pitch deck that outlines the business model, market opportunity, and team background. The firm prefers detailed information that highlights the startup's potential for growth and innovation.
Response times may vary, but founders should expect to hear back within a few weeks. Warm introductions can enhance the chances of receiving a timely response, so leveraging connections within the industry is advisable.
In recent activity, Redcliffe Capital has led seed rounds for startups, including Xanadu Heights, a San Francisco-based VR company. The firm continues to engage in 2-6 deals per year, focusing on early-stage investments in sectors such as healthcare and artificial intelligence.
As of 2023, Redcliffe Capital maintains its commitment to fostering innovation and sustainable value creation through its diverse investment strategies.
What are Redcliffe Capital's investment criteria?
Redcliffe Capital focuses on early-stage investments, particularly in seed and Series A rounds. The firm specializes in sectors such as artificial intelligence, healthcare, and fintech, seeking high-growth potential companies that demonstrate innovation and sustainability.
How can founders apply or pitch to Redcliffe Capital?
Founders can reach out to Redcliffe Capital via email at info@redcliffecapital.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Redcliffe Capital different from other investors?
Redcliffe Capital combines venture capital with special situations, structured finance, and leveraged buyouts, providing a unique multi-strategy approach to investments. This allows the firm to adapt to various market conditions and support portfolio companies in diverse ways.
What is the geographic scope of Redcliffe Capital's investments?
The firm operates globally, with a focus on North America, Europe, and Asia. This broad geographic reach enables Redcliffe Capital to identify and invest in innovative startups across different markets.
What is Redcliffe Capital's post-investment involvement like?
Redcliffe Capital provides strategic support to its portfolio companies, leveraging its expertise in venture capital and special situations to enhance growth and value creation. The firm actively engages with founders to navigate challenges and capitalize on opportunities.
What is the typical check size for investments made by Redcliffe Capital?
While specific check sizes are not disclosed, Redcliffe Capital primarily invests in seed and Series A rounds, which typically range from hundreds of thousands to several million dollars, depending on the startup's needs and growth potential.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.